glp-1 shortage guidance receptor agonists alter food experience and taste GLP-1 receptor agonist shortage expected

With major PBMs making formulary changes to GLP-1 coverage in 2026, the coverage status of specific medications is actively shifting

reported that semaglutide accessed the brainstem, hypothalamus, and the dorsal half of the septal area, largely via small circumventricular organs, but it was not shown to cross the BBB [27]

:

Real-world patients also tend to have more lifestyle support, ongoing medical relationships, and gradual dose reductions compared to the abrupt cessation in clinical trials

Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y, Zhang Y (2021) GLP-1 receptor agonists: beyond their pancreatic effects

GLP-1 is a 30 amino acid peptide produced by the L cells, enteroendocrine cells of the distal ileum and colon, and GIP is a 4 amino acid peptide produced by the K cells of the duodenum and jejunum